Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
paracasei LMG-S-26420 strain
Gossop, M., Griffiths, P., Powis, B
Urban population growth and dietary shifts are increasing obesity prevalence rates, creating expanding demand for medical weight management interventions
A dual GLP-1 and GIP receptor agonist, such as tirzepatide, stimulates both GLP-1 receptors and GIP (glucose-dependent insulinotropic polypeptide) receptors
Flavor Variations: Building Your Routine Eating the same thing every day causes diet fatigue
Key takeaways GLP-1 medications mimic a natural gut hormone that reduces appetite, controls blood sugar, and promotes satiety, often leading to significant weight loss Weight loss from GLP-1 medication use reduces the excess tissue mass that causes airway collapse and obstructive sleep apnea (OSA) severity, which can lead to fewer breathing interruptions, improved oxygen levels during sleep, and better overall sleep quality
